References
- Fjell CD, Hiss JA, Hancock REW, et al. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov. 2012;11(1):37–51.
- Hancock REW, Sahl H-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006;24(12):1551–1557.
- Kumar P, Kizhakkedathu JN, Straus SK. Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules. 2018;8(1):4.
- Andersson DI, Hughes D, Kubicek-Sutherland JZ. Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist Updat. 2016;26:43–57.
- Teng P, Huo D, Nimmagadda A, et al., Small antimicrobial agents based on acylated reduced amide scaffold. J Med Chem. 59(17): 7877–7887. 2016.
- Akhoundsadegh N, Belanger CR, Hancock REW. Outer membrane interaction kinetics of new polymyxin b analogs in gram-negative bacilli. Antimicrob Agents Chemother. 2019;63(10):e00935–19.
- Brilacidin [Internet]. Wakefield: INNOVATION. [cited2020 Feb 29]. Available from: http://www.ipharminc.com/brilacidin-1.
- Lytix Biopharma shelves clinical trial with LTX-109 in diabetic foot ulcers 2015 [Internet]. Oslo: Lytix Biopharma. [ cited 2020 Feb 29]. Available from: http://www.lytixbiopharma.com/news/317/130/Lytix-Biopharma-shelves-clinical-trial-with-LTX-109-in-diabetic-foot-ulcers.html.
- Varney KM, Bonvin AMJJ, Pazgier M, et al. Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II. PLoS Pathog. 2013;9(11):e1003732–e.
- Su M, Xia D, Teng P, et al., Membrane-active hydantoin derivatives as antibiotic agents. J Med Chem. 60(20): 8456–8465. 2017.
- Niu Y, Wang M, Cao Y, et al., Rational design of dimeric lysine N-alkylamides as potent and broad-spectrum antibacterial agents. J Med Chem. 61(7): 2865–2874. 2018.
- Teng P, Nimmagadda A, Su M, et al. Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential. Chem Commun. 2017;53(87):11948–11951.
- Choi S, Isaacs A, Clements D, et al., De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc Natl Acad Sci. 106(17): 6968–6973. 2009.
- Thaker HD, Sgolastra F, Clements D, et al. Synthetic mimics of antimicrobial peptides from triaryl scaffolds. J Med Chem. 2011;54(7):2241–2254.
- Ivankin A, Livne L, Mor A, et al. Role of the conformational rigidity in the design of biomimetic antimicrobial compounds. Angew Chem. 2010;49(45):8462–8465.